VAERS 2726927
GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZS9N
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 22.12.2023
- Impfdatum
- 12.12.2023
- Beginn
- 12.12.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Symptomtext
Administration of an expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 68-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZS9N, expiry date 24-SEP-2023) for prophylaxis. On 12-DEC-2023, the patient received the 2nd dose of Boostrix. On 12-DEC-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Administration of an expired dose). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-DEC-2023 The healthcare professional contacted GSK via phone inquiring about Boostrix and what information was available about the administration of an expired dose, which led to expired vaccine used. They asked not information about them be recorded but accepted follow-up. Partial information about vaccine, event and patient provided. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -